Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Pharmaceutical Da Ren Tang Group Jing Wan Hong is a specialized division of the Tianjin Pharmaceutical Da Ren Tang Group, focusing on the production of Traditional Chinese Medicine (TCM) for external use. The company is renowned for its flagship product, Jingwanhong Ointment, which is a staple in Chinese households for treating burns, scalds, and chronic wounds. With a history rooted in traditional herbal medicine, the company operates modern manufacturing facilities that adhere to GMP standards. Its product portfolio extends to treatments for hemorrhoids, arthritis, and various skin conditions, integrating ancient prescriptions with contemporary pharmaceutical science. As a 'China Time-honored Brand,' it plays a significant role in the preservation and modernization of Chinese medical heritage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Pharmaceutical Da Ren Tang Group Jing Wan Hong.